Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial

This was a randomized, double-blind clinical trial to compare the efficacy and safety of Atazanavir/Ritonavir (ATZ/RTV) with Lopinavir/Ritonavir (LPV/RTV) in moderate Coronavirus disease 2019 (COVID-19). Participants were randomly assigned to receive a single dose of hydroxychloroquine (HCQ) plus AT...

Descripción completa

Detalles Bibliográficos
Autores principales: Nekoukar, Zahra, Ala, Shahram, Moradi, Siavash, Hill, Andrew, Davoudi Badabi, Ali Reza, Alikhani, Ahmad, Alian, Shahriar, Moghimi, Minoo, Shabani, Amir Mohammad, Abbaspour Kasgari, Hamideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842611/
https://www.ncbi.nlm.nih.gov/pubmed/35194446
http://dx.doi.org/10.22037/ijpr.2021.115157.15243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842611/
https://www.ncbi.nlm.nih.gov/pubmed/35194446
http://dx.doi.org/10.22037/ijpr.2021.115157.15243

Ejemplares similares